Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05864209 · ClinicalTrials.gov registry record · NA

Phthalate and Bisphenol Exposure During Minipuberty

A NA study, sponsored by NYU Langone Health.

Completed
Registry status
NA
Development phase
10
Enrollment target

NCT05864209 is a NA study that has completed, run by NYU Langone Health. The registered enrollment target is 10 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05864209, a NA study, has completed, sponsored by NYU Langone Health.

COMPLETED
Registry status
NA
Development phase
10 participants
Enrollment target

Study Summary

Phthalates and bisphenols have been detected in a range of infant care products. This pilot study will test whether intervening on these sources of exposure during the critical period of minipuberty affects infants' body burden of phthalates and bisphenols. Investigators will recruit 10 participants from the ongoing NYU Children's Health and Development Study (CHES) cohort study who are \>=37 weeks gestation, carrying a male fetus, and intending to breastfeed. Investigators will randomly assign them to use either conventional baby products or phthalate- and bisphenol-free baby products for the first three months of their children's lives. Toward the end of the intervention, investigators will collect maternal breast milk and infant urine, and assay samples for phthalate metabolite and bisphenol concentrations.

Interventions

  • OTHER Phthalate- and Bisphenol-free Baby Products
  • OTHER Cloth Diapers
  • OTHER Conventional Disposable Diapers
  • OTHER Conventional Baby Products

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2023-05-16
Est. Completion 2024-01-11
Phase NA

Sponsor

NYU Langone Health

1,164 total trials

What the Registry Record Tells You About NCT05864209

The ClinicalTrials.gov registry entry for NCT05864209 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 4 interventions - of which Phthalate- and Bisphenol-free Baby Products is the first listed.

NCT05864209 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05864209 about?

NCT05864209 is a clinical study titled "Phthalate and Bisphenol Exposure During Minipuberty". Phthalates and bisphenols have been detected in a range of infant care products. This pilot study will test whether intervening on these sources of exposure during the critical period of minipuberty affects infants' body burden of phthalates and bisphenols. Investigators will recruit 10 participants...

What is the current status of trial NCT05864209?

This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2023-05-16. Estimated completion is 2024-01-11.

What interventions are being tested in trial NCT05864209?

The interventions under investigation include: Phthalate- and Bisphenol-free Baby Products (OTHER), Cloth Diapers (OTHER), Conventional Disposable Diapers (OTHER), Conventional Baby Products (OTHER).

Who is sponsoring clinical trial NCT05864209?

This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.